Frontiers in Immunology (Oct 2022)

New insights into iNKT cells and their roles in liver diseases

  • Xinyu Gu,
  • Qingfei Chu,
  • Xiao Ma,
  • Jing Wang,
  • Chao Chen,
  • Jun Guan,
  • Yanli Ren,
  • Shanshan Wu,
  • Haihong Zhu

DOI
https://doi.org/10.3389/fimmu.2022.1035950
Journal volume & issue
Vol. 13

Abstract

Read online

Natural killer T cells (NKTs) are an important part of the immune system. Since their discovery in the 1990s, researchers have gained deeper insights into the physiology and functions of these cells in many liver diseases. NKT cells are divided into two subsets, type I and type II. Type I NKT cells are also named iNKT cells as they express a semi-invariant T cell-receptor (TCR) α chain. As part of the innate immune system, hepatic iNKT cells interact with hepatocytes, macrophages (Kupffer cells), T cells, and dendritic cells through direct cell-to-cell contact and cytokine secretion, bridging the innate and adaptive immune systems. A better understanding of hepatic iNKT cells is necessary for finding new methods of treating liver disease including autoimmune liver diseases, alcoholic liver diseases (ALDs), non-alcoholic fatty liver diseases (NAFLDs), and liver tumors. Here we summarize how iNKT cells are activated, how they interact with other cells, and how they function in the presence of liver disease.

Keywords